Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08OJU
|
||||
| Former ID |
DIB009432
|
||||
| Drug Name |
SOU-001
|
||||
| Synonyms |
AA-10020; DRP-001
|
||||
| Indication | Urinary incontinence [ICD9: 788.3; ICD10:N39.3, N39.4, R32] | Discontinued in Phase 2 | [547251] | ||
| Company |
Arachnova Therapeutics Ltd
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-1B adrenergic receptor | Target Info | Modulator | [527154] | |
| Alpha-1A adrenergic receptor | Target Info | Modulator | [527154] | ||
| Alpha-1D adrenergic receptor | Target Info | Modulator | [527154] | ||
| NetPath Pathway | IL2 Signaling PathwayNetPath_14:IL2 Signaling Pathway | ||||
| Pathway Interaction Database | LPA receptor mediated events | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.